7390 Federal Register / Vol. 62, No. 33 / Wednesday, February 19, 1997 / Proposed Rules

PART 71—[Amended]

1. The authority citation for part 71

continues to read as follows:

Authority: 49 U.S.C. 106(g), 40103, 40113,

40120; E.O. 10854, 24 FR 9565, 3 CFR, 1959–

1963 Comp., p. 389; 14 CFR 11.69.

§ 71.1 [Amended]

2. The incorporation by reference in

14 CFR 71.1 of the Federal Aviation

Administration Order 7400.9D, Airspace

Designation and Reporting Points, dated

September 4, 1996, and effective

September 16, 1996, is amended as

follows:

Paragraph 6005 Class E airspace areas

extending upward from 700 feet or more

above the surface of the earth.

* * * * *

AGL SD E5 Spearfish, SD [Revised]

Black Hills-Clyde Ice Field, SD

(lat. 44°28′49′′N, long. 103°46′37′′W)

That airspace extending upward from 700

feet above the surface within a 7-mile radius

of the Black Hills-Clyde Ice Field Airport and

within 2.1 miles each side of the 305° bearing

from the airport extending from the 7-mile

radius to 8.3 miles northwest of the airport;

and that airspace extending upward from

1,200 feet above the surface within an area

bounded by a line beginning at lat.

44°29′22′′N, long. 103°56′48′′W; to lat.

44°13′37′′N, long. 104°14′00′′W; to lat.

44°18′41′′N, long. 104°23′24′′W; to lat.

44°44′11′′N, long. 103°57′49′′W; to lat.

44°50′13′′N, long. 103°28′11′′W; to lat.

44°47′27′′N, long. 102°57′40′′W; to lat.

44°39′31′′N, long. 102°56′34′′W; to lat.

44°38′27′′N, long. 103°12′26′′W; to lat.

44°25′29′′N, long. 103°38′30′′W; then

clockwise via the 7-mile radius of the airport

to the point of beginning.

* * * * *

Issued in Des Plaines, Illinois on February

5, 1997.

Maureen Woods,

Manager, Air Traffic Division.

[FR Doc. 97–4073 Filed 2–18–97; 8:45 am]

BILLING CODE 4910–13–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Ch. I

[Docket No. 96N–0364]

RIN 0910–AA20

Regulation of Medical Foods;

Extension of Comment Period

AGENCY: Food and Drug Administration,

HHS.

ACTION: Advance notice of proposed

rulemaking; extension of comment

period.

SUMMARY: The Food and Drug

Administration (FDA) is extending to

April 28, 1997, the comment period for

the advance notice of proposed

rulemaking for the regulation of medical

foods that published in the Federal

Register of November 29, 1996. This

action is being taken in response to

several requests from interested persons

for an extension of the comment period

on this document.

DATES: Written comments by April 28,

1997.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Robert J. Moore, Center for Food Safety

and Applied Nutrition (HFS–456), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–205–4605.

SUPPLEMENTARY INFORMATION: In the

Federal Register of November 29, 1996

(61 FR 60661), FDA published an

advance notice of proposed rulemaking

for the regulation of medical foods.

Interested persons were given until

February 27, 1997, to comment on the

advance notice of proposed rulemaking.

FDA has received requests for an

extension of the comment period from:

Manufacturers, a trade organization

representing manufacturers of medical

foods, and a professional society

representing health care providers and

research scientists. The interested

parties stated in their requests for an

extension of the comment period that

such an extension would help ensure

that the agency receives comprehensive

and carefully researched information

from experts to consider in response to

the notice. After careful consideration of

the requests submitted to the agency,

FDA has decided to grant an extension

of the comment period until April 28,

1997.

Interested persons may, on or before

April 28, 1997, submit to the Dockets

Management Branch (address above)

written comments regarding this

advanced notice of proposed

rulemaking. Two copies of any

comments are to be submitted, except

that individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday.

This document is issued under

sections 4, 5, and 6 of the Fair Packaging

and Labeling Act (15 U.S.C. 1453, 1454,

1455); sections 201, 301, 402, 403, 404,

405, 409, 411, 412, 501, 502, 503, 505,

and 701 of the Federal Food, Drug, and

Cosmetic Act (21 U.S.C. 321, 331, 342,

343, 344, 345, 348, 350, 350a, 351, 352,

353, 355, 371); and 21 U.S.C. 360ee(b)(3)

(section 5(b)(3) of the Orphan Drug

Amendments of 1988, as amended by

Pub. L. 100–290).

Dated: February 12, 1997.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–4021 Filed 2–18–97; 8:45 am]

BILLING CODE 4160–01–F

21 CFR Part 808

[Docket No. 96N–0249]

RIN 0910–AB03

Exemption From Preemption of State

and Local Cigarette and Smokeless

Tobacco Requirements; Applications

for Exemption Submitted by Various

State Governments

AGENCY: Food and Drug Administration,

HHS.

ACTION: Proposed rule.

SUMMARY: The Federal Food, Drug, and

Cosmetic Act (the act) preempts State

and local device requirements that are

different from, or in addition to, Federal

requirements under the act. The act also

provides that the Food and Drug

Administration (FDA) may, by

regulation, exempt State and local

device requirements from preemption.

FDA is responding to applications for

exemption submitted by the States of

Alabama, Alaska, Utah, and

Washington. FDA is proposing to grant

exemptions from Federal preemption for

certain cigarette and smokeless tobacco

requirements in the States of Alabama,

Alaska, and Utah. The requirements in

the State of Washington are not

preempted, and therefore no exemption

needs to be granted. Elsewhere in this

issue of the Federal Register, FDA is

announcing an opportunity for

interested persons to request a public

hearing on the proposed regulation.

DATES: Written comments by March 21,

1997. FDA proposes that any final rule

that may be issued based on this

proposal become effective 30 days after

the date of its publication in the Federal

Register.

ADDRESSES: Written comments to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

12420 Parklawn Dr., rm. 1–23,

Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Anne M. Kirchner, Office of Policy (HF–

23), Food and Drug Administration,